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25. Viral infection in children with bronchiectases 
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A. ZAWADZKA-KRAJEWSKA, J. LANGE AND R. KOZIOEK 
Department of Pediatric Pneumonology, Allergology and Hematology, Warsaw Medical University, 
01-184 Warsaw, 1 Dzialdowska St., Poland 
During 1994-1998, 28 children, aged from 2 to 14 years, with bilateral or unilateral bronchiectases were hospitalized in our 
clinic due to acute respiratory infections. In all cases, serological and enzymatic tests, tissue culture were performed to detect 
viral infection. In 14 cases we obtained confirmation of parainfluenza virus type 3 infection, adenovirus infection in seven 
cases, and Coxackie Bs + adenovirus in seven cases. In 23 cases administered treatment was only symptomatic - fenspiryde. In 
five cases (age from 2 to 3 years) bacterial culture of bronchoalveolar lavage was positive, patients were treated with 
antibiotics according to antibiograms. 
Conclusions: In children with bronchiectases in autumn months exacerbations of the disease are usually due to viral 
infections. Usually, symptomatic treatment is sufficient for recovery (good response to fenspiryde). In case of bacterial 
superinfection there is a need of antibiotic therapy according to antibiogram. In all cases of bronchiectases, additional 
antiviral and antibacterial immunization is required. 
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We studied the possibility of detection of respiratory viruses (RV) in RTI of newborns/infants. 
Antigens of Respiratory Syncytial Virus (RSV), Adeno-V(AV), Influenza A-V(IAV) and B-V(IBV) and Parainfluenzal,2,3- 
V(PiV) of 433 specimens of fresh respiratory secretions from patients (2m - 5y old) with pulmonary/bronchial infections were 
examined by microscopic IF assay. Two methods were used: a) IF on epithelial cells of specimens, b) IF after culture of 
specimens on MRC -5 and/or Hep -2 cells. On the whole, 1674 investigations were carried out with one or both methods: 428 
vs RSV, 282 vs AV, 370 vs IAVIIBV and 594 vs PiV. 
Positive specimens included 15.9% (81/510) of nasopharyngeal aspirates, 6.9% (211305) of nasal washes, 5.3% (37/695) of 
brushings, 3.1% (3/97) of bronchoalveolar lavages, 3.0% (l/33) of nasal swabs and 2.9% (1134) of other. RSV was found in 
29.7% (127/428) of investigations, ADV in 2.5% (71282) IAV/IBV in 1.1% (4/370) and PiV in 1% (6/594). 
Our data show that nasopharyngeal aspirate is the most suitable specimen to detect RV in RTI.These further support that 
the management of RTI in newborns/infants, especially those “at risk” or with bronchiolitis, should undergo virologic 
investigations by IF as an helpful diagnostic tool. 
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Background: Antibiotic resistance in pneumococci has emerged as an increasingly difficult clinical problem. Resistance patterns 
vary around the world, tending to be relatively low in the U.K. and U.S.A. and high in Africa and some parts of Europe. 
Within a particular geographical region one may expect to see different resistance patterns and bacterial carriage depending on 
the extent of antibiotic exposure. Other factors such as coexistent disease, which influences immune status, may be important. 
Objectives: To assess pharyngeal carriage of Streptococcus pneumoniae (pneumococcui) and Haemophilus inftuenzae type b 
(Hib) in HIV-positive children. 
Methods; Pharyngeal swabs were taken from 50 HIV-positive children (age range between 9 months to 13 years) in Nairobi, 
Kenya in July 1999. Two sets of swabs were taken from each child. One set was cultured locally and the other at the Royal 
London Hospital. Information regarding symptoms and current antibiotic treatment was documented. Local ethics approval 
was given. 
